<p>Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort</p>
Paolo Bonfanti(University of California San Diego), Giordano Madeddu(University of Sassari), Benedetto Maurizio Celesia(Ospedale Garibaldi), Chiara Molteni(Alessandro Manzoni Hospital), Giancarlo Orofino(Ospedale Amedeo di Savoia), Giuseppe Vittorio De Socio(University of Perugia), Nicola Squillace(Azienda Ospedaliera San Gerardo), Elena Ricci(Mario Negri Institute for Pharmacological Research), Barbara Menzaghi(Ospedale di Circolo di Busto Arsizio), E Salomoni(University of Sassari), Andrea De Vito(University of Sassari), Valeria Colombo(University of Milan), Chiara Dentone(Ospedale di Sanremo)
Cited by 14
Related Papers
Hospital-Acquired Infections in Critically Ill Patients With COVID-19
|CHEST Journal|2021|404
High rates of 30-day mortality in patients with cirrhosis and COVID-19
|Journal of Hepatology|2020|394
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study
|Clinical Infectious Diseases|2021|264
Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels
|medRxiv|2020|234
Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program
|Clinical Infectious Diseases|2012|208